Polyplex Corporation Q4 and Full-Year Fiscal 2026 Financial Results Announced
Polyplex Corporation has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported…
Rainbow Children’s Medicare Announces Financial Results and Leadership Reappointments
Rainbow Children’s Medicare Limited has reported strong financial performance for the quarter and financial year ended March 31, 2026. The…
Anupam Rasayan India Ltd. Appointment of Auditors for Fiscal Year 2026-27
Anupam Rasayan India Ltd. has announced the reappointment of its internal and cost auditors for the 2026-27 financial year. The board…
Anupam Rasayan India Ltd. Financial Results and Strategic Expansion Plans
Anupam Rasayan India Ltd. has reported its financial results for the quarter and year ended March 31, 2026. The company announced a final…
Polyplex Corporation Audited Financial Results for FY 2025-26
Polyplex Corporation has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.…
Anupam Rasayan India Ltd Resignation of Deputy CFO Vishal Thakkar
Anupam Rasayan India Ltd has announced the resignation of Mr. Vishal Thakkar, who served as the company’s Deputy Chief Financial Officer…
Anupam Rasayan India Ltd Strategic Acquisition of Bliss GVS Pharma Limited
Anupam Rasayan India Ltd has announced a strategic move to acquire up to 74.20% equity and control of Bliss GVS Pharma Limited. The…
Sarda Energy & Minerals Ltd Robust FY26 Financials Show Significant Growth
Sarda Energy & Minerals Ltd has delivered a strong performance for FY26, reporting a 20% CAGR in revenue to ₹5,928 crore. The company has…
Anupam Rasayan India Ltd Q4 FY26 Financial Results and Strategic Acquisition of Bliss GVS Pharma
Anupam Rasayan India Ltd has reported its financial results for the quarter and year ended March 31, 2026. The company recorded a standalone…
Anupam Rasayan India Ltd. Strategic Acquisition of Bliss GVS Pharma Limited
Anupam Rasayan has announced a strategic move to acquire up to 74.20% stake in Bliss GVS Pharma Limited, aiming to gain majority control. The…